The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $82.82

Today's change-0.72 -0.86%
Updated August 31 4:02 PM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $82.82

Today's change-0.72 -0.86%
Updated August 31 4:02 PM EDT. Delayed by at least 15 minutes.

Quest Diagnostics Inc crosses below 50-day moving average

Quest Diagnostics Inc closed lower Wednesday, dropping (U.S.)$0.72 or 0.86% to (U.S.)$82.82 and crossing below its 50-day moving average. Shares have lost 0.75% over the last five days, but sit 4.64% below their 52-week high. This security has outperformed the S&P 500 by 12.07% during the last year.

Key company metrics

  • Open(U.S.) $82.66
  • Previous close(U.S.) $83.54
  • High(U.S.) $83.03
  • Low(U.S.) $81.65
  • Bid / Ask(U.S.) $78.21 / (U.S.) $83.88
  • YTD % change+16.42%
  • Volume1,644,127
  • Average volume (10-day)1,176,947
  • Average volume (1-month)1,030,451
  • Average volume (3-month)1,139,405
  • 52-week range(U.S.) $59.66 to (U.S.) $86.85
  • Beta0.66
  • Trailing P/E14.49×
  • P/E 1 year forward16.36×
  • Forward PEG2.09×
  • Indicated annual dividend(U.S.) $1.60
  • Dividend yield1.93%
  • Trailing EPS(U.S.) $5.72
Updated August 31 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.59%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue1,9061,8631,8491,880
Total other revenue--------
Total revenue1,9061,8631,8491,880
Gross profit753720702730
Total cost of revenue1,1531,1431,1471,150
Total operating expense1,4841,6061,6101,249
Selling / general / administrative429440429399
Research & development--------
Depreciation / amortization17192020
Interest expense (income), net operating--------
Unusual expense (income)-11533-319
Other operating expenses, total0111-1
Operating income422257239631
Interest income (expense), net non-operating-35---36-35
Gain (loss) on sale of assets--------
Other--------
Income before tax392182214593
Income after tax209114200354
Income tax, total1836814239
Net income195102188342
Total adjustments to net income-100-2
Net income before extra. items195102188342
Minority interest-14-12-12-12
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items194102188340
Inc. avail. to common incl. extra. items194102188340
Diluted net income194102188340
Dilution adjustment--------
Diluted weighted average shares142144145145
Diluted EPS excluding extraordinary itemsvalue per share1.370.711.302.34
Dividends per sharevalue per share0.400.400.380.38
Diluted normalized EPSvalue per share0.930.721.321.03